Ignite Creation Date:
2024-05-06 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05031546
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-05-18
First Post:
2021-08-26
Brief Title:
Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Organization Data
Organization:
Cara Therapeutics Inc
Class:
INDUSTRY
Study ID:
CR845-500301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cara Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None